| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2007 | EP1749529A1 Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases |
| 02/07/2007 | EP1749528A1 Pharmaceutical combinations containing a mu opioid agonist and an inhibitor of NO production |
| 02/07/2007 | EP1749527A1 Use of substituted pyrazoline compounds for the treatment of the lipid parameters of the metabolic syndrome |
| 02/07/2007 | EP1749526A1 Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| 02/07/2007 | EP1749525A1 Combination of substituted pyrazolines and anti-addictive agent |
| 02/07/2007 | EP1749524A2 Inflammation-inhibiting compounds |
| 02/07/2007 | EP1749523A1 GSK-3 inhibitors |
| 02/07/2007 | EP1749522A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 02/07/2007 | EP1749521A1 Production method of nicotine transdermal preparation |
| 02/07/2007 | EP1749520A1 Water-dispersible encapsulated sterols |
| 02/07/2007 | EP1749519A1 Dosage form with pH-independent sustained release for active substances with pH-dependent solubility |
| 02/07/2007 | EP1749517A1 Stable pharmaceutical composition comprising linezolid form IV |
| 02/07/2007 | EP1749208A2 Functional ghs-r antagonists |
| 02/07/2007 | EP1749041A2 Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases |
| 02/07/2007 | EP1749039A1 Low molecular weight polylactic acid polymers |
| 02/07/2007 | EP1749030A1 A diabody which specifically binds streptococcus surface antigen i/ii and methods of use thereof |
| 02/07/2007 | EP1749017A2 Compounds and methods for cytoprotection |
| 02/07/2007 | EP1749016A2 Adenosine receptor agonists |
| 02/07/2007 | EP1749012A1 Muscarinic acetylcholine receptor antagonists |
| 02/07/2007 | EP1749011A1 Bicyclic heterocycles as hiv integrase inhibitors |
| 02/07/2007 | EP1749008A1 Bicyclic heterocycles as hiv integrase inhibitors |
| 02/07/2007 | EP1749007A2 Macrocyclic compounds as inhibitors of viral replication |
| 02/07/2007 | EP1749006A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/07/2007 | EP1749005A1 Tetrahydro-imidazo ¬1,5-a| pyridin derivatives as aldosterone synthase inhibitors |
| 02/07/2007 | EP1749004A1 Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents |
| 02/07/2007 | EP1749002A1 Pyrrole or imidazole amides for treating obesity |
| 02/07/2007 | EP1749001A1 3-piperidinylisochroman-5-ols as dopamine agonists |
| 02/07/2007 | EP1749000A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
| 02/07/2007 | EP1748997A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs |
| 02/07/2007 | EP1748996A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug |
| 02/07/2007 | EP1748995A1 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both |
| 02/07/2007 | EP1748994A1 Nitrooxyderivatives of antihypertensive drugs |
| 02/07/2007 | EP1748991A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents |
| 02/07/2007 | EP1748990A1 Process for the preparation of telmisartan |
| 02/07/2007 | EP1748989A2 Aryl sulfonamides |
| 02/07/2007 | EP1748985A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 02/07/2007 | EP1748984A1 Piperidine derivatives as nk1 and nk3 antagonists |
| 02/07/2007 | EP1748983A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 02/07/2007 | EP1748982A1 (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease |
| 02/07/2007 | EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists |
| 02/07/2007 | EP1748978A1 Carboxamido opioid compounds |
| 02/07/2007 | EP1748820A2 Dimethyl sulfone for the treatment of rosacea |
| 02/07/2007 | EP1748806A1 Biocompatible polyacrylate compositions for medical applications |
| 02/07/2007 | EP1748797A1 Preservative for medical devices |
| 02/07/2007 | EP1748794A2 Sequential sprm/progestin treatment |
| 02/07/2007 | EP1748793A2 Estrogen modulation of ifn-gamma-mediated conditions and diseases |
| 02/07/2007 | EP1748792A1 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same |
| 02/07/2007 | EP1748787A2 Method for fostering bone formation and preservation |
| 02/07/2007 | EP1748786A2 Dalbavancin compositions for treatment of bacterial infections |
| 02/07/2007 | EP1748784A2 Induction of innate immunity by vitamin d3 and its analogs |
| 02/07/2007 | EP1748783A2 Treatment or prevention of respiratory viral infections with immunomodulator compounds |
| 02/07/2007 | EP1748781A1 Methods for treating bleeding disorders using sulfated polysaccharides |
| 02/07/2007 | EP1748780A1 Methods and related compositions for reduction of fat |
| 02/07/2007 | EP1748779A1 Transdermal steroid formulation |
| 02/07/2007 | EP1748778A1 Controlled-release formulations containing vardenafil |
| 02/07/2007 | EP1748777A1 Controlled-release formulations containing vardenafil |
| 02/07/2007 | EP1748776A1 Compositions for affecting weight loss |
| 02/07/2007 | EP1748775A1 Pharmaceutical products for treating neoplastic disease and inflammation |
| 02/07/2007 | EP1748774A1 Compositions comprising flavonoids and tocotrienols and methods thereof |
| 02/07/2007 | EP1748773A1 Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 02/07/2007 | EP1748772A2 Combination therapies for cancer and proliferative angiopathies |
| 02/07/2007 | EP1748771A2 Composition for treating or preventing cell degeneration using at least one molecule capable of maintaining adhesion molecule expression reversibility and vascular endothelium actin fibre polymerisation |
| 02/07/2007 | EP1748770A1 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| 02/07/2007 | EP1748769A1 Antiviral composition comprising p-menthane-3,8-diol |
| 02/07/2007 | EP1748768A1 Novel compositions comprising higher primary alcohols and nicotinic acid and process of preparation thereof |
| 02/07/2007 | EP1748767A1 Diarylalkanes as potent inhibitors of binuclear enzymes |
| 02/07/2007 | EP1748764A2 An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production |
| 02/07/2007 | EP1748761A2 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins |
| 02/07/2007 | EP1748758A1 Spot-on formulation useful for cosmetology and dermatology |
| 02/07/2007 | EP1748757A1 An estradiol derivative or an estratopone derivative containing sustained release intraocular implant as well as related methods of manufacturing |
| 02/07/2007 | EP1748756A1 Compositions comprising drospirenone molecularly dispersed |
| 02/07/2007 | EP1748749A2 Systems and methods for treating panic attacks |
| 02/07/2007 | EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase |
| 02/07/2007 | EP1653895B1 Condom with a coating and composition |
| 02/07/2007 | EP1651622B1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/07/2007 | EP1626716B1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/07/2007 | EP1542753B1 Pharmaceutical compositions |
| 02/07/2007 | EP1536798B1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 02/07/2007 | EP1506211B1 C-aryl glucoside sglt2 inhibitors and method |
| 02/07/2007 | EP1503765A4 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| 02/07/2007 | EP1501504B1 1-substituted imidazole derivatives as nos inhibitors |
| 02/07/2007 | EP1421079B1 Thiophenyl compounds as medicaments |
| 02/07/2007 | EP1401813B1 New indole derivatives with 5-ht6 receptor affinity |
| 02/07/2007 | EP1397366B1 Novel ligand for nicotinic acetylcholine receptors useful in therapy |
| 02/07/2007 | EP1339419B1 Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa |
| 02/07/2007 | EP1315501B1 Alpha v integrin receptor antagonists |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | EP1231920B1 Use of epinastin for the treatment of allergic rhinitis/conjunctivitis |
| 02/07/2007 | EP1230241B1 Adenosine receptor antagonists and methods of making and using the same |
| 02/07/2007 | EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | EP1185525B1 4-heterocyclylsulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
| 02/07/2007 | EP1071677B1 Production of furanones |
| 02/07/2007 | EP1017680B1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 02/07/2007 | EP0998474B1 Piperazine derivatives |
| 02/07/2007 | EP0948646B1 Methods for identifying genes essential to the growth of an organism |
| 02/07/2007 | EP0870022B1 Immunostimulatory composition and method |
| 02/07/2007 | EP0833906B1 Novel ctla4/cd28 ligands and uses therefor |